Merck
MRK
#47
Rank
โ‚น26.093 T
Marketcap
โ‚น10,554
Share price
-1.68%
Change (1 day)
29.38%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): โ‚น637.91

According to Merck's latest financial reports the company's current EPS (TTM) is โ‚น676.93. an increase over its 2024 EPS that were of โ‚น626.20.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025โ‚น674.457.71%
2024โ‚น626.204308.46%
2023โ‚น14.20-97.32%
2022โ‚น530.8510.92%
2021โ‚น478.5984.68%
2020โ‚น259.15-27.2%
2019โ‚น355.9663.44%
2018โ‚น217.79151.11%
2017โ‚น86.73-54.58%
2016โ‚น190.9330.21%
2015โ‚น146.63-61.99%
2014โ‚น385.74180.51%
2013โ‚น137.51-31.82%
2012โ‚น201.696.62%
2011โ‚น189.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,032 52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น681.86 0.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น126.00-81.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น347.32-48.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,133 215.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,328 96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น191.32-71.74%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น275.15-59.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น349.08-48.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น114.88-83.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel